tiprankstipranks
Advertisement
Advertisement
Invivyd Earnings Call Highlights Trial Progress, Growth
PremiumCompany AnnouncementsInvivyd Earnings Call Highlights Trial Progress, Growth
23d ago
Invivyd post earnings selloff overdone, says H.C. Wainwright
Premium
The Fly
Invivyd post earnings selloff overdone, says H.C. Wainwright
23d ago
Invivyd Posts Strong Q1 Results, Advances VYD2311 Programs
Premium
Company Announcements
Invivyd Posts Strong Q1 Results, Advances VYD2311 Programs
23d ago
Invivyd provides update on Phase 3 DECLARATION study of VYD2311
PremiumThe FlyInvivyd provides update on Phase 3 DECLARATION study of VYD2311
2M ago
Invivyd announces discovery, advancement of measles antibody candidate VMS063
Premium
The Fly
Invivyd announces discovery, advancement of measles antibody candidate VMS063
2M ago
Invivyd Advances COVID-19 Program and Launches Measles Antibody
Premium
Company Announcements
Invivyd Advances COVID-19 Program and Launches Measles Antibody
2M ago
Invivyd reports cash, cash equivalents of $226.7M as of December 31
PremiumThe FlyInvivyd reports cash, cash equivalents of $226.7M as of December 31
3M ago
Invivyd appoints Michael Mina as CMO
Premium
The Fly
Invivyd appoints Michael Mina as CMO
3M ago
Invivyd reports FY25 EPS (30c) vs. ($1.43) last year
Premium
The Fly
Invivyd reports FY25 EPS (30c) vs. ($1.43) last year
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100